Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

BACKGROUND:Influenza and its associated diseases are a major cause of morbidity and mortality. The United States Advisory Committee on Immunization Practices recommends influenza vaccination for everyone over 6 months of age. The failure of the flu vaccine in 2014-2015 demonstrates the need for a mo...

Full description

Bibliographic Details
Main Authors: Daniel J Fullen, Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W Borley, Anthony Gilbert, Rob Lambkin-Williams
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4711822?pdf=render

Internet

http://europepmc.org/articles/PMC4711822?pdf=render

Similar Items